The Promise to Transform Medicine
The ability to replace organs and tissues on demand could save or improve millions of lives each year globally and create public health benefits on par with curing cancer. Unmet needs for organ and tissue preservation place enormous logistical limitations on transplantation, regenerative medicine, drug discovery, and a variety of rapidly advancing areas spanning biomedicine.
A growing coalition of researchers, clinicians, advocacy organizations, academic institutions, and other stakeholders has assembled to address the unmet need for preservation advances, outlining remaining challenges and identifying areas of underinvestment and untapped opportunities.
Meanwhile, recent discoveries provide proofs of principle for breakthroughs in a family of research areas surrounding biopreservation. These developments indicate that a new paradigm, integrating multiple existing preservation approaches and new technologies that have flourished in the past 10 years, could transform preservation research.
Sylvatica's founding team has a strong track record of bringing technologies from idea to clinic via venture capital funding, FDA go-aheads and IPOs. Our scientists include several fellows of the International Society for Cryobiology and members of the National Academies.
Wait not in vain
After decades of piecemeal progress, the science of cryogenically storing human organs is warming up
Core Concept: Cryopreservation aims to engineer novel ways to freeze, store, and thaw organs
Five years ago, even top cryobiologists doubted that a human organ would ever be successfully frozen and thawed.
U.S. Funds Efforts to Freeze Human Organs for Long-Term Storage
A glimmer of hope emerges for preserving transplantable livers and hearts in cold storage. As for brains—only in sci-fi…